Vertex Pharmaceuticals Incorporated logo

VRTXVertex Pharmaceuticals Incorporated

VRTX Stock Price, Valuation & Chart | Vertex Pharmaceuticals Incorporated

Compare
$499.74-9.01 (-1.77%)

At close · 16 Oct 2026, 08:00 pm

VRTX Historical price chart

VRTX Key Stats

Market Capitalization126.66B
PE Ratio26.26
EPS19.03
Trading Volume1.41M
Today's High/Low511.44/497.49
Dividend Yield0.00
52 Week High/Low560.25/403.16
Shares Outstanding253.46M
VRTX Financial Statement
VRTX Analyst ratings
VRTX Analysis & performance metrics

VRTX Company profile

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets…

VRTX Management team

Management
Kristen C. Ambrose CPA
Senior Vice President & Chief Accounting Officer
Jonathan Biller J.D.
Executive Vice President & Chief Legal Officer
Reshma Kewalramani FASN, M.D.CEO
Chief Executive Officer, President & Director
Ourania Tatsis Ph.D.
Executive Vice President and Chief Regulatory & Quality Officer
Susie Lisa C.F.A.
Senior Vice President of Investor Relations
Stephanie Franklin
Senior Vice President & Chief Human Resources Officer
David M. Altshuler M.D., Ph.D.
Executive Vice President & Chief Scientific Officer
Nina Devlin
Senior Vice President & Chief Communications Officer
Total 8 executives

VRTX Frequently asked questions

What is Vertex Pharmaceuticals Incorporated (VRTX) Stock Price?

Current stock price of Vertex Pharmaceuticals Incorporated (VRTX) stock is $499.74. The stock price is -1.77% lower in the session. The intraday range can be seen from this page. Volume of Vertex Pharmaceuticals Incorporated (VRTX) stock is 1.41M.

Last updated at 16 Oct 2026, 08:00 pm.

Why is the Vertex Pharmaceuticals Incorporated (VRTX) stock price going up or down today?

The stock price of Vertex Pharmaceuticals Incorporated (VRTX) can change with earnings, company news, and overall market sentiment. Vertex Pharmaceuticals Incorporated operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Vertex Pharmaceuticals Incorporated stock expensive at its current price?

Whether Vertex Pharmaceuticals Incorporated looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for VRTX on this page is 26.26. EPS on this page is 19.03. Compare those figures with peers and growth expectations before deciding if the current Vertex Pharmaceuticals Incorporated price is justified.

How has the stock price of Vertex Pharmaceuticals Incorporated (VRTX) performed historically?

Historical performance for Vertex Pharmaceuticals Incorporated (VRTX) is shown on the price chart on this page. Review multi-period moves alongside volume to see how VRTX reacted to past earnings and market events.

Should I buy Vertex Pharmaceuticals Incorporated (VRTX) stock, at this price?

Buying Vertex Pharmaceuticals Incorporated (VRTX) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.